Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • HM43239 for AML
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • HM43239 for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Careers
  • Contact

Press Releases

News

News

  • Press Releases
  • Presentations
  • Events

Aptose Bioscience Reports Results for the First Quarter Ended March 31, 2016

May 10, 2016 4:15pm EDT

Aptose To Release First Quarter Ended March 31, 2016 Financial Results and Hold Conference Call on May 10, 2016

May 02, 2016 8:00am EDT

Aptose Reports Fourth Quarter and Year End 2015 Results

Mar 29, 2016 4:10pm EDT

Aptose To Release Fourth Quarter and Year End December 31, 2015 Financial Results and Hold Conference Call on March 29, 2016

Mar 14, 2016 8:00am EDT

Aptose to Participate in Upcoming Investor Conferences

Mar 03, 2016 5:00pm EST

Aptose to Present at the 2016 RBC Capital Markets Global Healthcare Conference

Feb 18, 2016 5:00pm EST

Moffitt Cancer Center and Aptose Biosciences to Present Data on a Novel Class of Dual-Targeting Bromodomain / Kinase Inhibitors at 57th Annual American Society of Hematology (ASH) Meeting

Dec 03, 2015 8:00am EST

Aptose Biosciences to Participate in Upcoming Investor Conferences

Nov 30, 2015 5:00pm EST

Aptose Voluntarily Suspends Clinical Dosing of APTO-253 to Review Drug Manufacturing Processes and Procedures

Nov 20, 2015 7:30am EST

Aptose Biosciences Reports Results for the Third Quarter Ended September 30, 2015

Nov 10, 2015 4:05pm EST
RSS
  • Prev
    • 1...
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    Next
    © 2022 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap